Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0000898432-24-000011 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-01-03	2024-01-01	AMRX	Patel Gautam	Dir	G - Gift	$0.00	+1.60M	1.97M	+427%	$0
	2024-01-03	2024-01-01	AMRX	Patel Gautam	Dir	J - Other	—	-33.46M	374.3K	-99%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-01-01	G	A	1,598,115	$0.00	1,972,433	D	—	—
2	Common	Class A Common Stock	2024-01-01	J	D	33,458,067	—	374,318	D	—	—	(F1) The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.